Medco reports strong Q1 Exalgo to hit shelves this week Aton gains marketing rights for Lodosyn Amgen names new president, COO Decision Resources projects Vidaza will remain clinical gold standard through 2013 Genentech seeks expanded approval for Herceptin FDA advisory committees say Acurox approval lacks sufficient evidence FDA approves Zortress Abbott completes acquisition of Facet Biotech Study: Benlysta added to lupus treatments yields higher response rates First Previous 197 198 199 200 201 Next Last